(주)셀라스타

{
  "address": "인천광역시 연수구",
  "ceo_name": "장호연,전성하",
  "certificate": [
    {
      "cert_number": "20230816010007",
      "changes": "",
      "disclosure_date": "2023-08-16",
      "first_cert_date": "2023-08-16",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2023-08-16 ~ 2026-08-15"
    }
  ],
  "company_name": "(주)셀라스타",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 1165000000,
      "cost_of_sales": 0,
      "current_assets": 120348000,
      "current_liabilities": 834427000,
      "gross_profit": 0,
      "net_income": -392227000,
      "net_income_bs": -392227000,
      "non_current_assets": 1038350000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 27211000,
      "non_operating_income": 254000,
      "operating_profit": -365270000,
      "revenue": 0,
      "sga_expenses": 365270000,
      "total_assets": 1158698000,
      "total_equity": 324271000,
      "total_liabilities": 834427000
    },
    "2023": {
      "capital_stock": 1282500000,
      "cost_of_sales": 0,
      "current_assets": 225303000,
      "current_liabilities": 1137802000,
      "gross_profit": 0,
      "net_income": -431039000,
      "net_income_bs": -431039000,
      "non_current_assets": 1106531000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 41063000,
      "non_operating_income": 4803000,
      "operating_profit": -394779000,
      "revenue": 0,
      "sga_expenses": 394779000,
      "total_assets": 1331834000,
      "total_equity": 194032000,
      "total_liabilities": 1137802000
    },
    "2024": {
      "capital_stock": 1282500000,
      "cost_of_sales": 0,
      "current_assets": 56503000,
      "current_liabilities": 1307738000,
      "gross_profit": 0,
      "net_income": -159700000,
      "net_income_bs": -159700000,
      "non_current_assets": 1285566000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 51832000,
      "non_operating_income": 466428000,
      "operating_profit": -574296000,
      "revenue": 0,
      "sga_expenses": 574296000,
      "total_assets": 1342069000,
      "total_equity": 34331000,
      "total_liabilities": 1307738000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [
    {
      "amount": "300,800,000",
      "changes": "300,800,000",
      "date": "2023-07-17"
    }
  ],
  "main_products": "cap-1 항암제 개발 : 암세포의 침윤과 전이를 저해하는 항체의약품을 개발",
  "phone": "032-831-****",
  "years": [
    2024,
    2023,
    2022
  ]
}